Note 7 - Employee and Director Benefits (Tables)

9 Months Ended

Sep. 30, 2023

Notes Tables

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

						Weighted
				Weighted		Average
				Average		Remaining		Aggregate
				Exercise		Contractual		Intrinsic
	Shares			Price		Term (years)		Value
								(In Thousands)
Nine Months Ended September 30, 2023:
Outstanding at January 1, 2023		280,000		$	19.43		3.0	$	14,088
Exercised		(87,700	)		12.04		0.8		3,520
Forfeited		(1,000	)		34.09		5.3		18
Outstanding at September 30, 2023		191,300		$	22.65		3.4	$	6,235
Exercisable at September 30, 2023		139,300		$	17.12		1.7	$	5,051
Nine Months Ended September 30, 2022:
Outstanding at January 1, 2022		353,250		$	19.28		3.8	$	23,525
Exercised		(65,500	)		16.42		2.3		4,164
Forfeited		(1,500	)		35.21		5.8		67
Outstanding at September 30, 2022		286,250		$	19.51		3.4	$	18,431
Exercisable at September 30, 2022		225,500		$	14.89		2.3	$	14,990

Share-Based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]

	Restricted Stock					Performance Shares
	Shares			Weighted Average Grant Date Fair Value		Shares		Weighted Average Grant Date Fair Value
Nine Months Ended September 30, 2023:
Non-vested at January 1, 2023		141,580		$	56.39		23,852	$	54.16
Granted		49,415			60.29		8,091		70.29
Vested		(31,492	)		52.22		-		-
Forfeited		(11,733	)		64.78		-		-
Non-vested at September 30, 2023		147,770		$	57.92		31,943	$	58.25
Nine Months Ended September 30, 2022:
Non-vested at January 1, 2022		127,602		$	42.27		12,437	$	37.05
Granted		52,819			83.33		11,415		72.81
Vested		(26,563	)		43.51		-		-
Forfeited		(8,206	)		61.70		-		-
Non-vested at September 30, 2022		145,652		$	55.84		23,852	$	54.16